Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Valeant

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Valeant's Japan sales performance.

valeant

AZ sells Zurampic rights to Gruenenthal for $230m

AZ sells Zurampic rights to Gruenenthal for $230m In recent months the company has sold late-stage psoriasis candidate brodalumab to Valeant, transferred European rights to its opioid-induced constipation treatment Moventig (naloxegol) to ProStrakan and divested ex-US

Aduro pancreatic cancer vaccine trial disappoints

Aduro pancreatic cancer vaccine trial disappoints Add in the lacklustre commercial performance for Dendreon's (now Valeant's) Provenge - the only approved cancer vaccine - and the track record of the category makes for grim reading.

NewLink pancreatic cancer vaccine flunks phase III test

NewLink pancreatic cancer vaccine flunks phase III test Valeant's Provenge vaccine), with Genentech-partnered taxane drug GDC-0919 following on behind.

Deal Watch March 2016

Deal Watch March 2016 AstraZeneca, Roche, Sanofi and Valeant are featured in this month’s roundup of pharma deals. ... Valeant Pharmaceuticals, a company founded in 1989 which has tripled its revenues in three years through a high profile series of deals, has been the

Lilly's psoriasis drug Taltz cleared in Europe

Lilly's psoriasis drug Taltz cleared in Europe A third anti-IL-17 candidate - Valeant's brodalumab (just acquired from AstraZeneca) - could join the fray before the end of the year.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics